7-150951592-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_000238.4(KCNH2):c.1801G>A(p.Gly601Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.1801G>A | p.Gly601Ser | missense_variant | Exon 7 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461868Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 727234
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Long QT syndrome 2 Pathogenic:1
- -
Long QT syndrome Pathogenic:1
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 601 of the KCNH2 protein (p.Gly601Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with long QT syndrome (LQTS) (PMID: 9452080, 10862094, 18441445, 18752142, 19841300). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 67279). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 10226095, 12775586, 23303164). For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The p.G601S pathogenic mutation (also known as c.1801G>A), located in coding exon 7 of the KCNH2 gene, results from a G to A substitution at nucleotide position 1801. The glycine at codon 601 is replaced by serine, an amino acid with similar properties. This variant has been described in multiple patients with long QT syndrome (Akimoto K et al. Hum Mutat. 1998;Suppl 1:S184-6; Swan H et al. J Am Coll Cardiol. 1999;34(3):823-9; Splawski I et al. Circulation. 2000;102(10):1178-85; Nagaoka I et al. Circ J. 2008;72(5):694-9; Giudicessi JR et al. Circ Cardiovasc Genet. 2012;5(5):519-28). In several functional in vivo and in vitro analyses, this variant adversely affected the potassium ion channel, resulting in deficient protein trafficking and repolarization (Furutani M et al. Circulation. 1999;99(17):2290-4; Ficker E et al. J Biol Chem. 2002;277(7):4989-98; Jou CJ et al. Circ Res. 2013;112(5):826-30). In addition, based on internal structural analysis, this variant is anticipated to result in a significant decrease in structural stability (Wang W et al. Cell. 2017 04;169(3):422-430.e10). This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:9452080;PMID:10483966;PMID:10862094;PMID:16432067;PMID:18441445;PMID:18752142;PMID:19716085;PMID:19841300;PMID:21490315;PMID:21573751;PMID:10226095;PMID:11741928). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at